The effects of a newly developed
nicotinamide derivative,
N-(2-hydroxyethyl)nicotinamide nitrate (SG-75, Nicorandil), were examined in an experimental model of
angina pectoris, utilizing
methacholine-induced ECG changes as main parameter in intact anesthetized rats. The right carotid artery was exposed and through it a special
cannula was inserted to a point near the right and left coronary ostium. Such a device made it possible to inject drugs more selectively into the coronary artery. Single intra-aortic
injections of 4 to 8 micrograms of
methacholine caused a transient elevation of the ST segment and T wave of the electrocardiogram (ECG).
SG-75 (3 mg/kg i.v. or 10 mg/kg p.o.) prevented these changes in the ECG, while a potent
vasodilator,
papaverine, failed to do so. In the isolated, donor-perfused rat heart,
SG-75 (1-30 micrograms) injected into the coronary perfusion system caused dose-dependent vasodilation, while 0.1-0.8 micrograms
acetylcholine as well as
methacholine produced marked vasoconstriction.
SG-75 (10 mg/kg) administered orally to the donor rat inhibited the coronary vasoconstriction produced by the
cholinomimetic drugs, whereas
papaverine (30 micrograms i.a.) failed to prevent it. The inhibitory effects of
SG-75 on
methacholine-induced ECG changes in intact rats seemed to be due to its
spasmolytic action.